Visterra Inc.

📍 Waltham, United States🗓 Founded 2008👥 104 employees💰 Last funded Feb 2017
Biotechnology Research🌐 visterrainc.com
Website LinkedIn
Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases. Our proprietary technology platform enables the design and engineering of precision antibody-based product candidates that specifically bind to, and modulate, key disease targets. Applying this technology to disease targets that are not adequately addressed by traditional therapeutic approaches, we are developing a robust pipeline of novel therapies for patients with unmet needs. Our most advanced program is in Phase 2 clinical development. In addition, Visterra has established a number of partnerships to progress novel antibodies engineered to treat significant diseases with limited treatment options.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Canada
1
Frequently asked questions
Who invested in Visterra Inc.?
Visterra Inc. has 2 investors on record on gritt.io and 2 late-stage investors.
When did Visterra Inc. last raise funding?
The most recent investment in Visterra Inc. recorded on gritt.io was in February 2017.
When was Visterra Inc. founded?
Visterra Inc. was founded in 2008.
What industry is Visterra Inc. in?
Visterra Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Visterra Inc. based?
Visterra Inc. is headquartered in Waltham, United States.